Loading…
for educational and safety purposes
sci-wiki~$open stack theoretical-cancer-defense
cell and animal mechanisms, no human outcome data, and the word theoretical is doing real work
4 items; 4 structures drawn from pubchem.
⚠️ THE WORD THEORETICAL IS IN THE TITLE BECAUSE IT IS ACCURATE, AND THIS PAGE IS WHERE IT MATTERS MOST. Nothing in this stack has been shown to prevent or treat cancer in people. Three of the four have real cell and animal literature and no human outcome data for this purpose; the fourth has almost no literature at all. Reading this page as prevention would be a mistake and reading it as treatment would be a serious one.
Quercetin is a flavonoid found in onions, capers and apples, with senolytic activity demonstrated mainly in combination with dasatinib. ⚠️ It is also a meaningful inhibitor of several cytochrome P450 enzymes and of drug transporters, so its interaction surface is genuine and affects anything metabolised through those routes.
Carnosic acid is a rosemary diterpene acting through Nrf2, which is the transcription factor controlling the cell's endogenous antioxidant response. Upregulating the machinery is mechanistically more interesting than supplying antioxidants, and it is also the reason the interaction warning below applies to it particularly.
R-alpha lipoic acid is the biologically active enantiomer, which is why the R is specified; most inexpensive products contain the racemate, half of which is not the active form. ⚠️ It can lower blood glucose, which matters for anyone on glucose-lowering therapy.
⚠️ FOX-04-DRI DOES NOT BELONG IN THE SAME SENTENCE AS THE OTHER THREE WITHOUT SAYING SO. It is a cell-penetrating peptide, it is injectable, its evidence is a small number of mouse and cell studies, it has no human data whatsoever, and it is not a supplement in any sense. It is marked optional here, and optional understates it.
Three of these four are ordinary antioxidant and senolytic-adjacent compounds and one is not, and the honest description of the synergy has to start there rather than smoothing them into a single story.
Quercetin and FOX-04-DRI are both senolytic in intent, meaning they aim at senescent cells, which accumulate with age and secrete inflammatory signals. Quercetin's senolytic evidence is largely from combination work with dasatinib, a prescription cancer drug that is emphatically not in this stack and should not be inferred into it. FOX-04-DRI is a cell-penetrating peptide that disrupts the FOXO4 and p53 interaction to trigger apoptosis selectively in senescent cells, which is a far more targeted mechanism and a far thinner evidence base.
Carnosic acid works differently again: it activates Nrf2, so it upregulates the cell's own antioxidant machinery rather than scavenging directly. That is a more durable intervention than supplying an antioxidant, and it is also the one most likely to interact with therapies that work by oxidative stress. R-alpha lipoic acid is the metabolic cofactor, feeding pyruvate dehydrogenase and regenerating other antioxidants once spent.
Nothing attributable, and that is the only honest answer. There is no sensation associated with any of these mechanisms and no timescale on which one would be expected.
R-alpha lipoic acid can lower blood glucose noticeably in some people, which is the one perceptible effect in the roster and is a caution rather than a benefit.
Anyone using how they feel to judge whether this is working has no signal to read.
⚠️ NOTHING HERE SUBSTITUTES FOR SCREENING OR ONCOLOGY, AND THE MOST IMPORTANT THING ON THIS PAGE IS THAT A PERSON WITH A CONCERN SHOULD SEE A DOCTOR RATHER THAN READ FURTHER. ⚠️ ANTIOXIDANTS AND CANCER TREATMENT INTERACT IN A SPECIFIC AND CONTESTED WAY: several chemotherapies and radiotherapy work BY generating oxidative stress, and antioxidant supplementation during treatment is an active clinical controversy with a real possibility of reducing efficacy. Anyone under treatment needs their oncologist rather than this page. Quercetin inhibits CYP enzymes and drug transporters, which is exactly how an interaction with an oral cancer drug would happen. R-ALA lowers blood glucose.
nothing flaggedcurated roster
every pair here reads as compatible on the mechanisms the site holds. that is the absence of a known conflict, not a clearance.
3 of 4 in one basketAmazon
4 of 4 priced
no overlap found
no two of these share a primary class or a listed receptor. every item is pulling a different lever.
interested in protocols? join the discord; that is where dosing, timing and the practical side get discussed.
the sci-wiki publishes this as a description of what these compounds do together, not as a recommendation to take them. Nothing here is medical advice.